Cite

HARVARD Citation

    DiNardo, C. et al. (2021). Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid Leukemia. Journal of clinical oncology. 39 (1), pp. 57-65. [Online]. 
  
Back to record